Evidence map›Paper›PMID 28058996›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2017

Intranasal insulin treatment of an experimental model of moderate traumatic brain injury.

Fiona Brabazon, Colin M Wilson, Shalini Jaiswal, John Reed, William H Frey, Kimberly R Byrnes

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Computational,Biomedicines · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fiona Brabazon1 Neuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Colin M Wilson2 Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Shalini Jaiswal2 Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
John Reed1 Neuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
William H Frey4 Health Partners Neuroscience Research, St. Paul, MN, USA.
Kimberly R Byrnes1 Neuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Uniformed Services University of the Health Sciences · USCenter for Neuroscience and Regenerative Medicine · USHealthPartners · US

Funding

The NADPH oxidase enzyme as a therapeutic target after Spinal Cord InjuryR01NS073667 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BYRNES, KIMBERLY · 2012 to 2016
$1.3M
NINDS NIH HHS R01 NS073667
6 · The paper itself

Abstract

Traumatic brain injury (TBI) results in learning and memory dysfunction. Cognitive deficits result from cellular and metabolic dysfunction after injury, including decreased cerebral glucose uptake and inflammation. This study assessed the ability of intranasal insulin to increase cerebral glucose uptake after injury, reduce lesion volume, improve memory and learning function and reduce inflammation. Adult male rats received a controlled cortical impact (CCI) injury followed by intranasal insulin or saline treatment daily for 14 days. PET imaging of [18F]-FDG uptake was performed at baseline and at 48 h and 10 days post-injury and MRI on days three and nine post injury. Motor function was tested with the beam walking test. Memory function was assessed with Morris water maze. Intranasal insulin after CCI significantly improved several outcomes compared to saline. Insulin-treated animals performed better on beam walk and demonstrated significantly improved memory. A significant increase in [18F]-FDG uptake was observed in the hippocampus. Intranasal insulin also resulted in a significant decrease in hippocampus lesion volume and significantly less microglial immunolabeling in the hippocampus. These data show that intranasal insulin improves memory, increases cerebral glucose uptake and decreases neuroinflammation and hippocampal lesion volume, and may therefore be a viable therapy for TBI.

Indexed as

Administration, IntranasalAnimalsBlood GlucoseBrain Injuries, TraumaticFluorodeoxyglucose F18GlucoseHippocampusInsulinMagnetic Resonance ImagingMaleMaze LearningMemoryMicrogliaMotor ActivityPositron Emission Tomography Computed TomographyRatsBlood GlucoseFluorodeoxyglucose F18GlucoseInsulinGlucose uptakeintranasal insulinmicrogliapositron emission tomographytraumatic brain injury

Identifiers

PMID28058996
PMCPMC5584695
OpenAlexW2567971507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.